EOM Pharmaceuticals Holdings, Inc. (IMUC) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Montvale, NJ, 미국. 현재 CEO는 Irach Taraporewala.
IMUC 을(를) 보유 IPO 날짜 2021-01-08, 3 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $14.69M.
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
